{"id":706446,"date":"2026-01-10T00:12:12","date_gmt":"2026-01-10T00:12:12","guid":{"rendered":"https:\/\/www.europesays.com\/de\/706446\/"},"modified":"2026-01-10T00:12:12","modified_gmt":"2026-01-10T00:12:12","slug":"3%e2%81%ba-novo-nordisk-was-ist-bei-der-aktie-los-stock3","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/de\/706446\/","title":{"rendered":"(3\u207a) NOVO-NORDISK – Was ist bei der Aktie los ?! – stock3"},"content":{"rendered":"
    \n
  1. (3\u207a) NOVO-NORDISK – Was ist bei der Aktie los ?!<\/a>  stock3<\/li>\n
  2. Der B\u00f6rsen-Tag: Amazon Pharmacy startet Verkauf der Wegovy-Pille<\/a>  Ntv<\/li>\n
  3. Novo Nordisk: Turnaround nimmt Fahrt auf \u2013 50 Euro geknackt<\/a>  der aktion\u00e4r<\/li>\n
  4. Kurswechsel bei den Abnehm-Konkurrenten: Jetzt h\u00e4ngt Novo Nordisk pl\u00f6tzlich Eli Lilly ab<\/a>  B\u00f6rse Online<\/li>\n
  5. Novo Nordisk Aktie: Neue Studie sieht Kursziel bei 400 D\u00e4nischen Kronen<\/a>  4investors.de<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"(3\u207a) NOVO-NORDISK – Was ist bei der Aktie los ?!  stock3 Der B\u00f6rsen-Tag: Amazon Pharmacy startet Verkauf der Wegovy-Pille  Ntv…\n","protected":false},"author":2,"featured_media":706447,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[134],"tags":[175,170,169,29,30,171,174,173,172],"class_list":{"0":"post-706446","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-unternehmen-maerkte","8":"tag-business","9":"tag-companies","10":"tag-companies-markets","11":"tag-deutschland","12":"tag-germany","13":"tag-markets","14":"tag-maerkte","15":"tag-unternehmen","16":"tag-unternehmen-maerkte"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@de\/115867913044296434","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/de\/wp-json\/wp\/v2\/posts\/706446","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/de\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/de\/wp-json\/wp\/v2\/comments?post=706446"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/de\/wp-json\/wp\/v2\/posts\/706446\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/de\/wp-json\/wp\/v2\/media\/706447"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/de\/wp-json\/wp\/v2\/media?parent=706446"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/de\/wp-json\/wp\/v2\/categories?post=706446"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/de\/wp-json\/wp\/v2\/tags?post=706446"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}